Susquehanna Fundamental Investments’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $768K | Sell |
111,582
-39,061
| -26% | -$269K | 0.02% | 493 |
|
2025
Q1 | $434K | Sell |
150,643
-62,570
| -29% | -$180K | 0.01% | 878 |
|
2024
Q4 | $1M | Buy |
+213,213
| New | +$1M | 0.01% | 706 |
|
2023
Q3 | – | Sell |
-22,594
| Closed | -$74.6K | – | 457 |
|
2023
Q2 | $74.6K | Sell |
22,594
-18,940
| -46% | -$62.5K | ﹤0.01% | 614 |
|
2023
Q1 | $118K | Sell |
41,534
-43,024
| -51% | -$123K | ﹤0.01% | 893 |
|
2022
Q4 | $616K | Buy |
84,558
+26,758
| +46% | +$195K | 0.01% | 803 |
|
2022
Q3 | $468K | Buy |
+57,800
| New | +$468K | 0.01% | 1043 |
|
2021
Q4 | – | Sell |
-57,726
| Closed | -$1.63M | – | 1559 |
|
2021
Q3 | $1.63M | Buy |
+57,726
| New | +$1.63M | 0.03% | 671 |
|